Home
Conditions
Hepadnaviridae Infections

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,149 public trials 113 recruiting studies

Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Completed

Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults

NCT00697242

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Vienna, Austria

GSK Clinical Trials Call Center Ghent, Belgium

GSK Clinical Trials Call Center Hvidovre, Denmark

GSK Clinical Trials Call Center Reykjavik, Iceland

View Trial Details

Completed

Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults

NCT00696891

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Wilrijk, Belgium

GSK Clinical Trials Call Center Toronto, Canada

GSK Clinical Trials Call Center Gothenburg, Sweden

View Trial Details

Completed

Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants

NCT00697125

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Ghent, Belgium

View Trial Details

Completed

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).

NCT00697216

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Brussels, Belgium

GSK Clinical Trials Call Center Copenhagen, Denmark

View Trial Details

Completed

Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules

NCT00697229

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Wilrijk, Belgium

View Trial Details

Completed

PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients

NCT00644761

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Cedars Sinai Medical Center Los Angeles, California, United States

California Pacific Medical Center San Francisco, California, United States

University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV

NCT00645294

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Cliniques Universitaries Brussels, Belgium

J.W. Goethe-Universitat Frankfurt, Germany

Mid. Hochschule Hannover Kinderklinik Hanover, Germany

Kinderklinik der Gutenberg Universitat Mainz, Germany

View Trial Details

Completed

Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

NCT00023153

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +25 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Lamivudine for Chronic Hepatitis B

NCT00001457

Conditions: Arteritis, Blood-Borne Infections, Cardiovascular Diseases, +37 more
Locations: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States

View Trial Details

Completed

Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients

NCT00013702

Conditions: Ascites, Blood-Borne Infections, Bronchial Diseases, +33 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Hepadnaviridae Infections

Hepadnaviridae Infections trial results

Related conditions